Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Biopeptides, Corp in July, 2021 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44AI150060-02 | Phase II | 1,000,000 | July 16, 2021 | |||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp in June, 2020 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI150060-01A1 | Phase I | 300,000 | June 24, 2020 | |||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp in March, 2019 for $299,812.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142877-01 | Phase I | 299,812 | March 14, 2019 | |||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp in June, 2016 for $151,776.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI120364-01A1 | Phase I | 151,776 | June 10, 2016 | |||||||
A SBIR Phase II contract was awarded to Biopeptides, Corp in June, 2016 for $1,210,734.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI102435-03A1 | Phase II | 1,210,734 | June 15, 2016 | |||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp in January, 2016 for $176,282.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI122399-01 | Phase I | 176,282 | January 1, 2016 | |||||||
A STTR Phase I contract was awarded to Biopeptides, Corp in June, 2014 for $586,079.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41AI108006-01A1 | Phase I | 586,079 | June 11, 2014 | |||||||
A SBIR Phase II contract was awarded to Biopeptides, Corp for $860,668.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AI058364-02 | Phase II | 860,668 | ||||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp for $147,863.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AI058364-01A1 | Phase I | 147,863 | ||||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp for $299,571.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI074092-01 | Phase I | 299,571 | ||||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp for $143,157.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI052902-01 | Phase I | 143,157 | ||||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp for $299,996.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI072810-01 | Phase I | 299,996 | ||||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp for $600,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI096551-01 | Phase I | 600,000 | ||||||||
A SBIR Phase I contract was awarded to Biopeptides, Corp for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AI102435-01 | Phase I | 300,000 | ||||||||
A SBIR Phase II contract was awarded to Biopeptides, Corp for $2,066,280.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44AI074092-03 | Phase II | 2,066,280 |